Cheryl A. Jay
Impact in
- Virology top 5%
- HIV Research and Treatment
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
Papers in
-
- Metabolism and Genetic Disorders 3
- Virology 2
- HIV Research and Treatment 2
- Co-authors
- Starley B. ShadeDonald I. AbramsMichael E. KellyKarin L. PetersenHaatem RedaMichael C. RowbothamNeal L. BenowitzMarinos C. Dalakas
- Journals
- Neurology (4 papers)Acta Neuropathologica (2 papers)Annals of Neurology (2 papers)Clinical Infectious Diseases (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Cheryl A. Jay
17 papers receiving 1000 citations
Peers
Comparison fields: 5 of 90
- Virology 161
- Pharmacology 509
- Toxicology 83
- Emergency Medicine 172
- Clinical Biochemistry 97
Countries citing papers authored by Cheryl A. Jay
This map shows the geographic impact of Cheryl A. Jay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Jay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Jay more than expected).
Fields of papers citing papers by Cheryl A. Jay
This network shows the impact of papers produced by Cheryl A. Jay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Jay. The network helps show where Cheryl A. Jay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheryl A. Jay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 3 | |
| 2 | 2014 | 3 | |
| 3 | 2013 | 92 | |
| 4 | 2010 | 11 | |
| 5 | 2008 | 19 | |
| 6 | 2007 | 180 | |
| 7 | Cannabis in painful HIV-associated sensory neuropathy | 2007 | 14 |
| 8 | 2007 | 427 | |
| 9 | 2006 | 30 | |
| 10 | 2003 | 5 | |
| 11 | 2000 | 13 | |
| 12 | 1999 | 63 | |
| 13 | 1995 | 55 | |
| 14 | 1995 | 46 | |
| 15 | 1995 | 4 | |
| 16 | 1994 | 83 | |
| 17 | 1994 | 10 |
About Cheryl A. Jay
Cheryl A. Jay is a scholar working on Clinical Biochemistry, Virology, Infectious Diseases, Microbiology and Emergency Medicine, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Metabolism and Genetic Disorders (3 papers), Cannabis and Cannabinoid Research (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers), HIV Research and Treatment (2 papers), Pain Mechanisms and Treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Advanced MRI Techniques and Applications (2 papers). The work is most often cited by research in Virology (161 citations), Pharmacology (509 citations), Toxicology (83 citations), Emergency Medicine (172 citations) and Clinical Biochemistry (97 citations). Cheryl A. Jay has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Starley B. Shade, Donald I. Abrams, Michael E. Kelly, Karin L. Petersen, Haatem Reda, Michael C. Rowbotham, Neal L. Benowitz, Marinos C. Dalakas, Marta Leon‐Monzon and Isa Bernardini. Their work appears in journals such as Neurology, Acta Neuropathologica, Annals of Neurology, Clinical Infectious Diseases and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.